SUNSET 🫁
↪️ maximally tolerated dose of SBRT for ultra-central non-small cell lung carcinoma
📍 60 Gy in 8 daily fractions ✅

T1-3N0M0
30 patients
≤ 30% rate of grade 3-5 ➡️ 6,7%
3-year OS=72,5% & PFS=66,1% & LC=89,6%

OncoAlert #OncoAlertAF

redjournal.org/article/S0360-…

TCa D12
Metastatic NSGCT, rx'd BEP ▶️ TIP chemo
Multiple stable lung mets
2 mets increase☠️☠️
In comes #SBRT 🤠🤠
Both mets responded, markers ⬇️
FU 3 yrs+, no acute/late tox, no progression🤞🏽🤞🏽

Is NSGCT *really* radioresistant, or just 2Gy-resistant?🤯
#TestisCancer

How cool is this?!! Superstar UCSD MSTP MD/PhD student Meghana Pagadala PhD is doing a clinical #radonc rotation with my friend Vedang Murthy!!

I love this photo and the friendships forged in shared efforts to improve #ProstateCancer care

🇺🇸🇮🇳

A new phantom study from Dr. Seyi Oderinde (Oluwaseyi (Seyi) Oderinde, PhD) shows the promise of Biologically Guided Radiation Therapy (BgRT). In the case of a moving target, BgRT delivered higher doses to the target compared to SBRT. American Association of Physicists in Medicine RefleXion Medical
aapm.onlinelibrary.wiley.com/doi/10.1002/mp…

Learned a lot in #thoracic #SBRT at the UCSF Helen Diller Family Comprehensive Cancer Ctr UCSF Health #radonc CME course from speakers Lucas Vitzthum Katelyn Hasse, Ph.D. Dr. David Palma Sue Yom and Dr. Nam Woo Cho #lcsm

This week we held one of our annual Stereotactic Body Radiation Therapy (SBRT) training courses! This three-day course covers a variety of topics including the evolution of SBRT, guidelines for proper treatment, treatment planning on two systems, as well as physics and dosimetry.

Congratulations to Percy Lee MD, our medical director of radiation oncology, on his reelection to the Board of Directors of the Radiosurgery® Society, the largest society dedicated to novel radiosurgery and SBRT treatment paradigm in the world.

The society is dedicated to the…

Thanks John H. Shin MD | MGH Spine highlighting our work!

Retrospective
🔹111 patients, SBRT for Spine Metastases
🔹Endplate Disruption➡️Novel Risk factor for vertebral compression fracture in patients undergoing SBRT
🔹High Risk: SINS >7, Endplate Disruption, Breast/Lung/Colorectal Histology

Great talk by Dr. Rebecca Snyder on complications in the Alliance for Clinical Trials in Oncology borderline PDAC trial 👏👏👏

To SBRT, or to not SBRT. That is the question….😂

#oncsurgery #SSO2024 #endcancer MD Anderson Cancer Center Kelly K Hunt Peter WT Pisters, MD Ching-Wei D. Tzeng

15-year results of the CAP #ProstateCancer screening trial. n=415,357 in 🇬🇧 randomized to single invitation for a PSA test vs no invitation

Richard Martin

jamanetwork.com/journals/jama/…

Some interesting breakfast companions in 🇲🇽 entertained my youngest son

Huge congrats to our ventricular tachycardia #SBRT team in expanding treatment options for our patients UCSF Health ! Thanks to Sue Yom for the invite to share our work with UCSF Cardiology at the UCSF Helen Diller Family Comprehensive Cancer Ctr #radonc course today! Emily Hirata Edward Gerstenfeld Drs Lin, Hsia, Dewland

Truly an honor to be a part of this massive effort. The CAP and ProtecT trials are remarkable and will continue to inform our understanding for decades.

And what an amazing team to work with!! 🙏🏼 Richard Martin Freddie Hamdy et al.

Preliminary results of ProScreen trial: RCT, n=60,745 in 🇫🇮, comparing invitation to screen (PSA➡️4K➡️MRI) vs no invitation

jamanetwork.com/journals/jama/…

📢 A randomized phase-III Trial Result:
⭐️Dose-intensified stereotactic body radiotherapy (SBRT) for painful vertebral metastases outperforms conventional external beam radiotherapy (cEBRT) in pain relief.
⏩SBRT group: 69.4% experienced pain reduction by 2 or more points at 6…

#SBRT showing similar long term QOL outcomes to Surgery for stage 1 #NSCLC with improved QOL in the initial period post treatment compared to surgery!
Great to see data supporting our clinical experience and enhancing decision making for patients. 👏🏼 🫁 ☢️
Drew Moghanaki 🐕…

Big thanks to QuadShot News for the shout out today! Very proud of our RTQA analysis of Alliance for Clinical Trials in Oncology study on neoadjuvant #SBRT for #pancreaticcancer . Thanks to Joseph Michael Herman and team for letting me a part of this great work! Michael Chuong Eugene J. Koay, MD, PhD

Sean Collins Prostate SBRT@Georgetown University This patient could have been included in PACE-B. With 5-year BCF without ADT around 96% modern SBRT doesnt leave much room for improvement with adding ADT

Rescate con SBRT guiada por PET-PSMA tras prostatectomía. Parece que es el camino a seguir,... con incógnitas por resolver:
- ¿BAC?¿duración?
- ¿CTV electivo o solo GTV?
- ¿ #GTV máx?
Necesarios estudios.
No es tratamiento estándar.

Interesting results advocating SBRT for painful vertebral metastasis, although the study was closed early for slow accrual. The 10 fr regimen for epidural disease seems a promising alternative to common palliative schemes!